The first homemade medical cannabis products will debut on the German market within weeks. This comes as Eurox Group – the producer of the range of derivative – has secured €3m growth capital from leading UK cannabis investors Fast Forward Innovations. And, after securing over £10m of investment to date, Eurox has started work on its first cultivation asset in Portugal. Speaking to BusinessCann Bernhard Babel, co-Managing Director of Eurox, said: “The final details are being sorted and the products will be launched within weeks. Ambition To Secure 20% Of Market “There will be a range of oils – and later we will be releasing APIs including Dronabinol.” The oils will feature a balanced one-to-one ratio CBD to THC, a 25-to-one ratio THC to CBD, and a predominant CBD oil, with more to follow in the autumn. Its ambition is to secure between 10 to 20% of the domestic derivatives market which accounts for 50% of the total German market. With the German market currently valued at around €200m Eurox is preparing for a period of rapid growth.

Cannabis Business Executive – Cannabis and Marijuana industry news, 07/07/2021 20:07:00

Open article: